Literature DB >> 11324753

Molecular cloning and high-level expression of G2 protein of hantaan (HTN) virus 76-118 strain in the yeast Pichia pastoris KM71.

S H Ha1, J J Park, J W Kim, J W Jeong, K S Noh, Y J Jeon, H S Kim, H B Kim.   

Abstract

Hantaan viral G2 envelope gene, which is known to be one of major antigens and induce neutralizing antibodies, was cloned into expression vector pHIL-S1 which consists of AOX1 promoter, PHO1 signal sequence, HIS4 gene and other components. The recombined plasmid was transformed into methylotropic yeast, Pichia pastoris of KM71 and recombinant strains harboring multi-copy of G2 gene were selected. Expression of the cloned G2 gene was confirmed with Western blot analysis using anti-sera of guinea pig immunized with the carboxyl terminal region of G2 protein expressed in Escherichia coli. The expression of G2 gene from the recombinant strain was tightly repressed by dextrose and effectively induced by methanol, an inducer of AOX1 promoter. The highest expression level was observed from 1 day after induction and maintained at the same level for up to 4 days.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11324753     DOI: 10.1023/a:1008173212708

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  18 in total

1.  High-level expression of tetanus toxin fragment C in Pichia pastoris strains containing multiple tandem integrations of the gene.

Authors:  J J Clare; F B Rayment; S P Ballantine; K Sreekrishna; M A Romanos
Journal:  Biotechnology (N Y)       Date:  1991-05

2.  Nucleotide sequence of the L genome segment of Hantaan virus.

Authors:  C S Schmaljohn
Journal:  Nucleic Acids Res       Date:  1990-11-25       Impact factor: 16.971

3.  Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine.

Authors:  Y C Yoo; K Yoshimatsu; Y Koike; R Hatsuse; K Yamanishi; O Tanishita; J Arikawa; I Azuma
Journal:  Vaccine       Date:  1998 Jan-Feb       Impact factor: 3.641

4.  Development of inactivated vaccine against virus causing haemorrhagic fever with renal syndrome.

Authors:  K Yamanishi; O Tanishita; M Tamura; H Asada; K Kondo; M Takagi; I Yoshida; T Konobe; K Fukai
Journal:  Vaccine       Date:  1988-06       Impact factor: 3.641

5.  Hantaan virus: identification of virion proteins.

Authors:  L H Elliott; M P Kiley; J B McCormick
Journal:  J Gen Virol       Date:  1984-08       Impact factor: 3.891

6.  Coding strategy of the S genome segment of Hantaan virus.

Authors:  C S Schmaljohn; G B Jennings; J Hay; J M Dalrymple
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

7.  Hantaan virus M RNA: coding strategy, nucleotide sequence, and gene order.

Authors:  C S Schmaljohn; A L Schmaljohn; J M Dalrymple
Journal:  Virology       Date:  1987-03       Impact factor: 3.616

8.  Analysis of Hantaan virus RNA: evidence for a new genus of bunyaviridae.

Authors:  C S Schmaljohn; J M Dalrymple
Journal:  Virology       Date:  1983-12       Impact factor: 3.616

9.  Preparation of candidate vaccinia-vectored vaccines for haemorrhagic fever with renal syndrome.

Authors:  C S Schmaljohn; S E Hasty; J M Dalrymple
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

10.  Recombinant Bordetella pertussis pertactin (P69) from the yeast Pichia pastoris: high-level production and immunological properties.

Authors:  M A Romanos; J J Clare; K M Beesley; F B Rayment; S P Ballantine; A J Makoff; G Dougan; N F Fairweather; I G Charles
Journal:  Vaccine       Date:  1991-12       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.